Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2

Chunhui Wang; Suwei Lan; Bing Han; Xingcha Wang

doi:10.22514/ejgo.2026.050

Article Menu

Export Article

Article Data

Views 196
Dowloads 147

This is a correction to: European Journal of Gynaecological Oncology. 2024; 45(3): 62-67. https://doi.org/10.22514/ejgo.2024.049

Corrections

Open Access

Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2

Chunhui Wang^1,*,
Suwei Lan¹
Bing Han¹
Xingcha Wang¹

¹Department of Gynecology, Affiliated Hospital of Chengde medical university, 067000 Chengde, Hebei, China

DOI: 10.22514/ejgo.2026.050 Vol.47,Issue 3,October 2026 pp.153-153

Published: 15 October 2026

*Corresponding Author(s): Chunhui Wang E-mail: chunhui1233@163.com

PDF (231.66 kB) View Full-text

Cite and Share

Chunhui Wang, Suwei Lan, Bing Han, Xingcha Wang. Correction: Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2. European Journal of Gynaecological Oncology. 2026; 47(3): 153-153. doi: 10.22514/ejgo.2026.050

URL:

https://www.ejgo.net/articles/10.22514/ejgo.2026.050

References

[1] Wang CH, Lan SW, Han B, Wang XC. Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2. European Journal of Gynaecological Oncology. 2024; 45: 62–67.